Reviva Pharmaceuticals Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 0 shares for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2022-08-15
- Reviva Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 47.46K shares, a 219.69% increase from fiscal 2019.
- Reviva Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 14.85K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-15 | |
| 2020-12-31 | 47.46K shares 10-K · filed 2022-03-15 | |
| 2019-12-31 | 14.85K shares 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |